Millennium Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-90,000
Closed -$8.98M – 3718
2018
Q3
$8.98M Buy
90,000
+15,000
+20% +$1.24M 0.01% 1393
2018
Q2
$5.33M Buy
+75,000
New +$6.29M 0.01% 1774

Other funds holding ANAB

Millennium Management's ANAB Position: Q3 2026 in Review

Millennium Management reduced its AnaptysBio (ANAB) stake by 2.8% in Q3 2026, selling an estimated $1.29M and leaving 784,560 shares worth $39.4M. The position accounts for 0.01% of the portfolio, ranked #1087.

Millennium Management first reported a position in ANAB in Q1 2017 and has held it in 37 quarters since. The position peaked at $54.5M in Q2 2026. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Millennium Management held 784,560 shares of AnaptysBio worth $39.4M as of Q3 2026.
  • Millennium Management sold 22,756 AnaptysBio shares in Q3 2026, an estimated $1.29M.
  • AnaptysBio made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1087 holding.
  • Millennium Management first reported a position in AnaptysBio in Q1 2017 and has held it in 37 quarters since.
  • Millennium Management's AnaptysBio position peaked at $54.5M in Q2 2026.
  • 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.